treatment of thrombosis Flashcards

1
Q

what are the three processes that occur to limit blood loss after BV damage?

A
  1. vasoconstriction
  2. platelet adherence and aggregation to plug hole
  3. blood coagulation to lay down fibrin in the hole and providing a scaffold for repair
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is a red thrombus?

A

the occlusion of veins by fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is a white thrombus?

A

the occlusion of an artery by platelet aggregation

fast flow deters fibrin deposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what activates the intrinsic pathway of the blood coagulation cascade?

A

atherosclerosis via suface contact activating factor XII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what activates the extrinsic pathway of the blood coagulation cascade?

A

when factors are introduced into circulation, those factors come from damaged cells, those activate factor VII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the factors that promote coagulation (that can be deficient)

A
factor VIII (type A haemophilia)
factor IX: type B haemophilia 
Vitamin K: this is required for the carboxylation of glutamic acid residues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the endogenous anti-coagulants?

A

thrombomodulin:

  • inhibits factor II,V and VII
  • prevents coagulation in the extrinsic pathway and the common pathway

anti-thrombin III:

  • inhibit thrombin, by stimulating factors that inhibit thrombin
  • inhibits all activated factors of intrinsic pathway and factor X
  • does not affect extrinsic pathway

heparin co-factor II:
- inhibits activated thrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how does heparin work?

A

combines with and accelerates the action of anti-thrombin III

  • increases rate of complex formation - so that thrombin inactivation is almost instantaneous
  • inactivates IIa, Xa, IXa and XIIa
  • pro-thrombin III must be present for heparin to work
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how is heparin administered?
onset?
when is it used?
duration?

A

heparin can be administered SC or IV (but IV is preferred)
has immediate onset
low dose heparin is used pre-operatively to reduce risk of deep vein thrombosis

works for 2-4 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the antagonist of heparin?

A

protamine sulphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is a major problem of using heparin? alternatives?

A

heparin sensitisation/resistance is a problem. so substitute compounds are used instead (e.g. dalteparin/ this has a longer duration of action)

other alternatives:
- hirudin 
blocks factor II 
- danapiroid
blocks factor X 
- ancrod 
causes fibrinolysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how does warfarin work?

A

interfere with the reduction of vitamin K

  • prevents the gamma carboxylation of factor II, VII, IX and X
  • if those factors are not carboxylated they become non-functional
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how is warfarin different to heparin

A

heparin increases the rate of a physiological process
warfarin inhibits the reduction of vitamin K

heparin is given IV warfarin is given orally

also warfarin is inactive in vitro will heparin is

warfarin has a half life of 40 hours, while heparin has a duration of action of 2-4 hours

rate of onset of warfarin s much longer than for heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the main dangers of using warfarin?

A

main hazard is bleeding, but can be treated with vitamin K

  • the vitamin K is given IV
  • but no response is illicited until new factors are synthesised
  • haemorrhage may require immediate treatment by whole blood transfusions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

explain the reason behind the rate of onset of warfarin? how do clinicians deal with this?

how can the rate of onset by altered?

A

the rate of onset of warfain depends on the half life of the factors (because it can only prevent carboxylation of the factors, it does NOT decarboxylate)

  • the half life of factors X and II is 40 and 60 hours
  • meaning for warfarin to decrease the efficacy of the clotting cascade (some of the carboxylated clotting factors must be reduced)

therefore, if an immediate effect is required heparin is given in addition to warfarin

the rate of onset of warfarin can be quicker in patients with fever of hyperthyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how is the dose of warfarin controlled

A

dose must be controlled through frequent monitoring - usually this is achieved through INR (inter nation normalised ratio) - this reports patient’s prothrombin time compared to that of a normal control
2-4: 1 is the usual aim
risk of bleeding significantly increases if >4

17
Q

what reduces the response to the oral coagulants?

A

prior administration of drugs that causes induction of mixed oxidases

  • (cytochrome P450-linked in the liver which metabolises oral anti-coagulants) e.g. phenytoin
  • oral contraceptives (NEVER given with warfarin)
  • hyperthermia/pyrexia
18
Q

what increases the response to oral coagulants?

A

displacement of anti-coagulants from plasma proteins - e.g. aspirin/phenytoin

  • impairment of platelet aggregation (aspirin)
  • inhibition of mixed oxidases in the liver
    (imipramine, cimetidine)
  • reduction of vitamin k availability (broad spectrum availability)
  • increased catabolism of clotting factors (thyroxin)
  • inhibition of metabolism (metronidazole, erythromycin)
  • liver disease
19
Q

how is the fibrinolytic system activated

A

by activation of the intrinsic coagulation system

20
Q

what does activation of the fibrinolytic system involve?

A

this involves the formation of plasminogen activators. plasminogen is found on fibrin strands, PA have a very short half life, they activate plasminogen –> plasmin which digests fibrin and fibrinogen.

plasmin that escapes into circulation is inactivated by plasma inhibitors

21
Q

how does streptokinase work?

A

non-enzymatic protein extracted from cultures of streptococci.
forms a stable complex with plasminogens, this confers a shape change in them activating their enzymic activity
- – this drug does not act directly
this drug is antigenic, and its affect can be reduced by anti-streptococcal antibodies already present

22
Q

how does urokinase work? where is it from?

A

can be made using recombinant DNA technology. can also be prepared from human urine, or human embryonic kidney cells

enzymic and acts directly as a plasminogen activator

not antigenic

23
Q

what are the advantages of using TPA?

A

can be made using recombinant DNA technology

more active on fibrin bound plasminogen than on plasma plasminogen - therefore, clot selective

24
Q

what is APSAC, how is it used?

A

a complex of human lys- plasminogen and streptokinase (inactive due to presence of para-anisoyl group in its catalytic centre)
this group is removed in the blood

can be given as a single IV injection over 4-5 minutes and its fibrinolytic activity is maintained for 4-6 hours

25
Q

what are the absolute contraindications of fibrinolytic drugs

A

active internal bleeding

cerebrovascular disease

26
Q

what are the relative contraindications of fibrinolytic drugs?

A

procedures in which clot formation is important (e.g. surgery)
anti-coagulants should be given cautiously with fibrinolytic drugs

27
Q

what is tranexamic acid

A

inhibits plasminogen activation

prevents fibrinolysis

28
Q

what is amniocaproic acid?

A

inhibits plasminogen activation (like tranexamic acid) but less potent

29
Q

what is aprotinin?

A

inhibits proteolytic enzymes
used in hyperplasminaemia (which can be produced by fibrinolytic drugs)

used in disseminated intravascular coagulation
used in treatment of acute pancreatitis

30
Q

what is chemical used in blood transfusions to prevent blood coagulating?

A

citrate dextrose

31
Q

what is citrate dextrose?

how does it work?

A

dextrose:
- a plasma expander and it is used to maintain blood volume and baroreceptor reflex

citrate:

  • a calcium chelator
  • calcium is required for the conversion of II –> IIa by factor X
  • citrate functionally removes calcium from the plasma

inside the body citrate is metabolised by the citric acid cycle

32
Q

when is tranexamic acid used?

A
  • used in women with menorrhagia
  • used in people with increased risk of haemorrhages
  • people with bleeding disorders